Wegovy was approved for chronic weight management for patients ages 12 and older
Regular check-ins, coaching, and lab reviews help us tailor your plan and address any side effects or concerns that may arise
Now, victims are taking legal action against Dupixent's manufacturers to pursue compensation for the harm they've suffered
Aunque la semaglutida tambin ha demostrado eficacia en el control del peso , conviene aclarar una confusin muy extendida: la marca aprobada especficamente para el tratamiento de la obesidad y el sobrepeso es Wegovy (semaglutida a dosis de hasta 2,4 mg), no Ozempic
Ensure adequate daily intake of calcium (700mg), vitamin D (10 micrograms), and protein, engage in regular weight-bearing exercise such as walking or strength training, and discuss any concerns with your GP, particularly if you have pre-existing bone health risk factors